Evidence map›Paper›PMID 36313487›Full record

ArticleFrontiers in neurology2022

Cross-sectional analysis of clinical aspects in patients with long-COVID and post-COVID syndrome.

Hannah Schulze, Jeyanthan Charles James, Nadine Trampe, Daniel Richter, Thivya Pakeerathan, Nadine Siems, Ilya Ayzenberg, Ralf Gold, Simon Faissner

Abstract read
In one paragraph

Article in Frontiers in neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. [Treatment of severe post-COVID syndrome].MMW Fortschritte der Medizin · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hannah SchulzeDepartment of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.
Jeyanthan Charles JamesDepartment of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.
Nadine TrampeDepartment of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.
Daniel RichterDepartment of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.
Thivya PakeerathanDepartment of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.
Nadine SiemsDepartment of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.
Ilya AyzenbergDepartment of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.
Ralf GoldDepartment of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.
Simon FaissnerDepartment of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Regarding pathogenesis, clinical manifestations, at-risk individuals, and diagnostic methods for stratifying patients for therapeutic approaches, our understanding of post-COVID syndrome is limited. Here, we set out to assess sociodemographic and clinical aspects in patients with the long-COVID and post-COVID syndrome. Methods: We performed a cross-sectional analysis of patients presenting at our specialized university hospital outpatient clinic. We assessed patients' clinical presentation, fatigue, symptoms of depression and anxiety, and impairment of smell. Results: A total of 101 patients were included (73.3% female), of whom 78.2% had a mild course of COVID-19. At presentation, 93.1% suffered from fatigue, 82.2% from impaired concentration, and 79.2% from impaired memory, 53.5% had impaired sleep. The most common secondary diagnosis found in our cohort was thyroid disease. Fatigue analysis showed that 81.3% of female and 58.8% of male patients had severe combined fatigue. Female gender was an independent risk factor for severe fatigue (severe cognitive fatigue OR = 8.045, Interpretation: Most long-COVID patients suffered from severe fatigue, with the female sex as an independent risk factor. Fatigue was not associated with symptoms of depression or anxiety. Patients with long-COVID symptoms should receive an interdisciplinary diagnostic and therapeutic approach depending on the clinical presentation.

Indexed as

anxietyCOVID-19depressionfatiguepost-COVID syndromeSARS-CoV-2smell disorder

Identifiers

PMID36313487
PMCPMC9614029

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.